Use of thioflavin radiolabeled derivatives in amyloid imaging gor assessing anti-amyloid therapies

Details for Australian Patent Application No. 2005270026 (hide)

International Classifications

Event Publications

1 February 2007 PCT application entered the National Phase

PCT publication WO2006/014381 Priority application(s): WO2006/014381

25 June 2009 Alteration of Name

The name of the applicant has been altered to University of Pittsburgh - of the Commonwealth System of Higher Education

13 January 2011 Amendment Made

The nature of the amendment is: Amend invention title to read Use of thioflavin radiolabeled derivatives in amyloid imaging for assessing anti-amyloid therapies 2009

24 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.